Candel Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.1M | 823k | 6.20 |
| 2024-03-31 | $75k | 48k | 1.58 |
| 2023-09-30 | $46k | 50k | 0.92 |
| 2023-06-30 | $65k | 52k | 1.26 |
| 2023-03-31 | $63k | 47k | 1.35 |
| 2022-12-31 | $70k | 39k | 1.79 |
| 2022-06-30 | $416k | 129k | 3.22 |